AC Immune (ACIU) FCF Margin Growth (1y) (2016 - 2025)
Powered by 
Analysis
AC Immune (ACIU) FCF Margin Growth (1y) (2016 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 811.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19,111.00 |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -544,786.00 |
| Sep 30, 2025 | -192,834.00 |
| Jun 30, 2025 | -1.19 Mn |
| Dec 31, 2020 | -84,923.00 |
| Sep 30, 2020 | -141,617.00 |
| Jun 30, 2020 | -25,330.00 |
| Mar 31, 2020 | -16,576.00 |
| Dec 31, 2019 | 25.58 Mn |
| Sep 30, 2019 | 55,724.00 |
| Jun 30, 2019 | -75,355.00 |
| Mar 31, 2019 | 93,024.00 |
| Dec 31, 2018 | -25.70 Mn |
| Sep 30, 2018 | 16,923.00 |
| Jun 30, 2018 | 74,480.00 |
| Mar 31, 2018 | -27,917.00 |
| Dec 31, 2017 | 50,798.00 |
| Sep 30, 2017 | -135,858.00 |
| Jun 30, 2017 | -107,773.00 |
| Mar 31, 2017 | 97,244.00 |
| Dec 31, 2016 | 130,448.00 |